Understanding the use of PARPi combinations to treat patients with mCRPC

ESMO 2024: Optimising the personalisation of prostate cancer treatment

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC

Breastfeeding after breast cancer is safe

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC

Intraoperative radiotherapy at Fortis Healthcare Hospital

Intraoperative radiotherapy: Techniques, applications, and evidence

Managing emotional issues in cancer survivors

Addressing challenges in pediatric oncology: eating, sleeping difficulties, and procedural anxiety

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer